OMNIQ (OMQS) $10.00, Announces Record $25 Million in New Orders, 100% Growth in AI-Based...
OMNIQ Announces Q4 2020 Revenue, up 12% YoY achieving $13 Million in Q4 Revenue; Growth Accelerates in Q1 2021 with a...
2021 Breakthrough Wearable Tech: Overview on Hapbee (HAPB, HAPBF) and its Vision
LIVE CHART
https://youtu.be/X_DRzL6MAOU
Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to Biotech Six Pack.
The 2021 Biotech Six Pack: Stocks We Expect to Double!
These are ideas #3 and #4 for the 'Biotech...
News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.
Of course, approval news is the ultimate "as huge as it gets" news.
But at this stage...
Adding Hepion Pharma (HEPA) $1.73 to Watch List.
Adding Hepion Pharma ($1.73) to Watch List. Oh My. What Did We Find Here?
Oh my…and Oh boy....
OmniQ (OMQS) Lands Another $6.6 Million in New Orders.
OMNIQ Receives $6.6 Million in New Orders from a Leading U.S. Supermarket Chain for "Touchless" Real-time Data Collection and Analysis Solutions
Hepion Pharma (HEPA): News Archive
UPDATED CONTINUOUSLY..
12/31/2020: News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.
12/23/2020: Remember...
OMNIQ (OMQS) Corp. Acquires Eyepax Parking Assets.
OMNIQ Corp. Acquires Eyepax USA's Intellectual Property and Technology to Establish Leadership in Multibillion Dollar Automated Parking Solutions Market
Draganfly (DFLYF) Closes $15 Million Reg A Offering.
Draganfly Enters Agreement with Applied Research and Innovations Services at Southern Alberta..
The Company announces that it has...
Draganfly (DFLYF) Holds ‘Pole Position’ in Race for Drone Supremacy After Chinese Barred from...
STREETWISE REPORTS - March 3, 2020
The company establishes a toehold with U.S....
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
